IRVINE, Calif.-- (BUSINESS WIRE)-- Masimo (NASDAQ:MASI) announced today FDA 510 (k) clearance and full market release of Rad-97™ Pulse CO-Oximeter ®, including configurations with integrated NomoLine™ ...

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking of Eve™, a critical congenital heart disease (CCHD) newborn screening application, for the Rad-97™ Pulse ...

Masimo Corp. in Irvine now sells its MightySat pulse oximeter in about 100 Apple stores and on Apple.com. It previously had been available only online at a roster of websites that include Amazon.com ...

Eliminating racial bias in pulse oximetry has been top of mind lately for many devicemakers and healthcare providers, as well as the FDA, which convened an advisory committee meeting earlier this ...

Wearable devices have become essential to clinical research, as they enable research studies to collect health-related data on patients around the clock. These devices, which includes commercial ...

Masimo Corporation MASI recently presented the findings of an abstract study, which explored the efficiency of Masimo noninvasive and continuous hemoglobin monitoring SpHb as part of the transfusion ...

As the founder and chief executive of Masimo Corp., I co-invented the modern day, measure-through motion and low perfusion pulse oximeter (SET Pulse Oximeter) and have spent my life in pursuit of data ...

Masimo Corporation MASI recently announced the publication of the results of a prospective study in the Sri Lanka Journal of Child Health, demonstrating the efficacy of using Masimo Signal Extraction ...

About a week after the FDA convened its latest meeting to discuss strategies for reducing racial biases in widely available pulse oximetry technology, Masimo has released new study data suggesting ...